|
Market Closed -
Nasdaq
04:00:00 2026-09-09 pm EDT
|
5-day change | 1st Jan Change | ||
| 391.27 USD | -0.48% |
|
-10.69% | +19.54% |
| Sep. 08 | US Equity Indexes Drop as Houthi Strikes on Saudi Arabia's Energy Infrastructure Lift Crude Oil | MT |
| Sep. 08 | Amgen-AstraZeneca lung cancer drug combo boosts survival in late-stage trial | RE |
| Market Cap | 213B 183B 172B 157B 293B 20,221B 295B 2,036B 787B 10,306B 798B 781B 32,636B | P/E 2026 * |
24.7x | P/E 2027 * | 22.1x |
|---|---|---|---|---|---|
| Enterprise Value | 254B 218B 206B 188B 351B 24,167B 352B 2,433B 941B 12,317B 954B 933B 39,005B | EV / Sales 2026 * |
6.52x | EV / Sales 2027 * | 6.17x |
| Free-Float |
99.77% | Yield 2026 * |
2.58% | Yield 2027 * | 2.72% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMGN | Delayed | |
CBOE
| AMGN | Real-time | |
|
Tradegate
| AMG | Real-time | |
|
Xetra
| AMG | Delayed | |
|
Boerse Muenchen
| AMG | Real-time | |
|
CBOE
| 0R0T | Real-time | |
|
Wiener Boerse
| AMGN | End-of-day quote | |
|
Börse Stuttgart
| AMG | Delayed | |
|
Borsa Italiana
| 1AMGN | End-of-day quote | |
|
CBOE
| Real-time | ||
|
London S.E.
| 0R0T | Delayed | |
|
Mexican S.E.
| AMGN * | End-of-day quote | |
|
Deutsche Boerse AG
| AMG | Delayed | |
|
Berne S.E.
| 000907582 | End-of-day quote | |
|
Santiago S.E.
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGNCL | End-of-day quote |
Last Transcript : Amgen Inc.
| 1 day | -0.48% | ||
| 1 week | -10.69% | ||
| Current month | -8.98% | ||
| 1 month | -4.79% | ||
| 3 months | +13.17% | ||
| 6 months | +5.88% | ||
| Current year | +19.54% |
| 1 week | 389.28 |  | 445.82 |
| 1 month | 389.28 | | 447.03 |
| Current year | 318.21 | | 447.03 |
| 1 year | 269.77 | | 447.03 |
| 3 years | 249.7 | | 447.03 |
| 5 years | 198.64 | | 447.03 |
| 10 years | 133.64 | | 447.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 2012-04-30 |
| Director of Finance/CFO | 62 | 2010-05-12 | |
Sean Bruich
CTO | Chief Tech/Sci/R&D Officer | - | 2024-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 2012-12-31 |
Tyler Jacks
BRD | Director/Board Member | 65 | 2011-12-31 |
Robert Eckert
BRD | Director/Board Member | 71 | 2011-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Other | Chief Financial Officer | 34,061 | 0.0063% | ||
| 8/13/26 | Exercice | Executive/Senior Manager | 3,756 | 0.0007% | ||
| 8/7/26 | Free | Director | 85 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.48% | -10.69% | +39.64% | +50.82% | 213B | |
| +0.03% | -3.09% | +52.20% | +91.69% | 1,002B | |
| -0.76% | -1.52% | +49.94% | +66.34% | 649B | |
| +0.86% | -3.49% | +19.60% | +68.37% | 440B | |
| -0.80% | +0.06% | +28.73% | +35.45% | 346B | |
| -0.13% | -14.74% | +9.13% | +26.71% | 263B | |
| -1.90% | -2.61% | -2.67% | +7.41% | 250B | |
| -1.06% | -1.70% | -16.73% | -57.36% | 201B | |
| -0.68% | -2.85% | +25.69% | +91.64% | 182B | |
| -0.04% | -2.70% | +13.16% | -18.89% | 158B | |
| Average | -0.40% | -2.12% | +21.87% | +36.22% | 370.21B | |
| Weighted average by Cap. | -0.19% | -2.40% | +31.55% | +53.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.94B 33.47B 31.54B 28.74B 53.74B 3,704B 53.96B 373B 144B 1,888B 146B 143B 5,978B | 40.23B 34.58B 32.59B 29.7B 55.53B 3,827B 55.75B 385B 149B 1,951B 151B 148B 6,177B |
| Net income | 8.74B 7.51B 7.08B 6.45B 12.06B 831B 12.11B 83.69B 32.36B 424B 32.8B 32.09B 1,342B | 9.36B 8.05B 7.58B 6.91B 12.92B 891B 12.97B 89.68B 34.67B 454B 35.14B 34.39B 1,437B |
| Net Debt | 41.49B 35.66B 33.6B 30.62B 57.25B 3,947B 57.49B 397B 154B 2,011B 156B 152B 6,370B | 35.83B 30.8B 29.02B 26.45B 49.45B 3,408B 49.65B 343B 133B 1,737B 134B 132B 5,501B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-09 | $391.27 | -0.48% | 2,828,468 |
| 26-09-08 | $393.17 | -10.08% | 6,831,664 |
| 26-09-04 | $437.23 | -1.55% | 1,656,089 |
| 26-09-03 | $444.12 | +0.29% | 1,842,496 |
| 26-09-02 | $442.84 | +1.08% | 2,286,291 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
